Menu
Not yet recruiting NCT06896591

Deep Posterior Post Gluteal Compartment Block in Total Hip Arthroplasty: Feasability and Safety

No phase Interventional Total Hip Arthroplasty

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: Deep posterior post gluteal nerve block.
Who it may be relevant to
Registry conditions: Total Hip Arthroplasty. Basic parameters: from 18 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
Center list to be confirmed — check the primary protocol.
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →

Unsure about the terms? Read our patient guide →

Official title

Effets D'un Bloc Glutéal Postérieur Profond Associé À Un PENG Bloc Dans La Prothèse Totale De Hanche

Overview

This study aims to evaluate the effectiveness of a posterior hip capsule block performed in addition to a PENG (Pericapsular Nerve Group) block for patients undergoing hip arthroplasty. The primary objective is to assess whether this combined approach provides enhanced perioperative analgesia compared to the standard analgesic protocol or the PENG block alone. Secondary outcomes will focus on opioid consumption, functional recovery, and any potential complications. By targeting both the anterior and posterior innervation pathways around the hip joint, this combined technique could improve patient comfort, decrease opioid requirements, and potentially expedite rehabilitation after hip arthroplasty.

Interventions

  • Procedure Deep posterior post gluteal nerve block
    One injection with ultrasound guidance injection of 5, 10 or 15 mL of naropeine 0.35 % Procedure : injection below the piriformis muscle in front of the head of the femur.

Primary outcome measures

  • Sciatic nerve block [Time frame: From enrollment to the end of treatment at 1 month]
Secondary outcome measures (5)
  • Pain postoperative [Time frame: From enrollment to the end of treatment at 1 MONTH]
  • pain 2 [Time frame: From enrollment to the end of treatment at 1 MONTH]
  • oPIOID Consumption [Time frame: From enrollment to the end of treatment at 7 months]
  • RAAC [Time frame: From enrollment to the end of treatment at 1 MONTH]
  • Surgical complication [Time frame: From enrollment to the end of treatment at 1 MONTH]

Eligibility criteria

Inclusion criteria

All adults with total hip arthroplasty

\-

Exclusion criteria

  • Contraindication to regional anesthesia
  • allergy
  • refusal of the injection

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Allocation
N/A
Model
Single group
Masking
Open label
Primary purpose
Treatment

Study locations

Center list to be confirmed — check the primary protocol.

Publications

  • Pun M, Ng T, Vermeylen K, Tran J. Innervation of the hip joint: implications for regional anaesthesia and image-guided interventional pain procedures. BJA Educ. 2024 Jun;24(6):191-202. doi: 10.1016/j.bjae.2024.02.005. Epub 2024 Apr 8. No abstract available. PMID 38764441

Identifiers

NCT: NCT06896591 · COS-RGDS-2024-06-039-P-ELMALEH

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗